A carregar...
Larotrectinib in a NTRK‐rearranged soft tissue sarcoma in the neoadjuvant setting: A case report
Patients with soft tissue sarcomas should be assessed for neurotrophic tropomyosin receptor kinase (NTRK) gene fusions as neoadjuvant treatment with larotrectinib may prevent amputation.
Na minha lista:
| Publicado no: | Clin Case Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7981750/ https://ncbi.nlm.nih.gov/pubmed/33768917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3878 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|